Personalized Therapeutics Seminars (2010)
| The Personalized Therapeutics Seminar series began in August 2008 and replaces the former seminar series. Personalized Therapeutics Seminars are held on Tuesdays from 11:00am-noon in conference room W7120 (Wishard Myers Building (WD), 7th Floor). Campus Map 2007 Schedule | 2008 Schedule | 2009 Schedule | 2010 Schedule | 2011 Schedule | 2012 Schedule |
|||
| Date | Presenter | Title | Topic |
| JAN 5 | James Rae | Genetic Predictors of Response to Breast Cancer Anti-Estrogen Therapy | |
| JAN 12 | David Jones | The Quantification of Drug for in vivo Phenotyping of Five CYPs after Low Dosage Administration | |
| JAN 19 | No Seminar | ||
| JAN 26 | Sara Quinney | Drug Metabolism Changes during Pregnancy | |
| FEB 2 | No Seminar | ||
| FEB 9 | Beth Pflug | Expanding Benzodiazepines into Cancer Therapeutics | |
| FEB 16 | Zeruesenay Desta | Efavirenz: Metabolism, Drug Interactions and Pharmacogenetics | |
| FEB 23 | Silvana Borges | The Role of Pharmacogenomics in Drug Development: A Regulatory Respective | |
| MAR 2 | Caryn Lerman | Pharmacogenetic Approaches to Nicotine Addiction Treatment | |
| MAR 9 | |||
| MAR 16 | ASCPT | No Seminar | |
| MAR 22 | Prof. Nick Holford (1-2pm) |
Professor, Clinical Pharmacology Department of Pharmacology and Clinical Pharmacology University of Auckland |
Three Strikes; You’re Out – Why traditional statistical practice is stopping therapeutic progress in Parkinson’s disease |
| MAR 23 | Anuradha Ramamoorthy | Mechanisms of variability in CYP2D6 Metabolism: The contributions of polymorphisms, copy number variations and microRNA | |
| MAR 30 | No Seminar | ||
| APR 6 | Rolf Kreutz | Interventional Cardiology Fellow Krannert Institute of Cardiology Indiana University |
Platelet P2Y12 Receptor Inhibitors - Personalized Therapeutics One Step at a Time |
| APR 13 | No Seminar | ||
| APR 20 | No Seminar | ||
| APR 27 | Malaz Boustani, M.D. | Associate Professor of Medicine; Adjunct Assoc Professor in Public Health | Rapid Translation from Discovery to delivery – the Case of HABC and IDND |
| APR 29 | Yuyan Jin, PhD | FDA Fellow Division of Pharmacometrics, School of Pharmacy University of Pittsburgh |
Public Health Model for the Evaluation of the Management of Hypertension – A Proposal |
| MAY 4 | Jasper Stevens, MSc | Leiden University | Preclinical biomarker model to study the PK-PD relationship of dopaminergic agents following intranasal administration in freely moving rats |
| MAY 11 | Beth Pflug | Indiana University Division of Clinical Pharmacology |
Expanding Benzodiazepines into Cancer Therapeutics |
| MAY 18 | Michelle Rudek | Johns Hopkins University | The Clinical Pharmacology of Sorafenib in Patients with Acute Leukemias |
| MAY 19 | Jason Bazil | Weldon School of Biomedical Engineering, Purdue University | An Integrated Bioenergetics Modeling Approach to Mitochondrial Permeability Transition |
| MAY 25 | Thomas Hudson, MD Second Annual Harry & Edith Gladstein Visiting Professor |
President & Scientific Director, Ontario Cancer Research Institute |
Genome Variation and Cancer |
| JUN 1 | No Seminar | ||
| JUN 8 | No Seminar | ||
| JUN 15 | No Seminar | ||
| JUN 30 | Professor Juergen Thomale, PhD | Head DNA Repair Lab, Institute of Cell Biology; Member Center of Medical Biotechnology, University of Essen | Formation and repair of cisplatin-DNA damage: mouse lessons on drug resistance and side effects |
| JUL 6 | No Seminar | ||
| JUL 13 | No Seminar | ||
| JUL 21 | Eric Sherer, PhD | Fellow Candidate, Modeling Program | An Adaptive – Predictive Model of Colonic Neoplasia at Colonscopy |
| JUL 27 | No Seminar | ||
| AUG 3 | No Seminar | ||
| AUG 10 | No Seminar | ||
| AUG 17 | No Seminar | ||
| AUG 24 | No Seminar | ||
| AUG 31 | No Seminar | ||
| SEP 7 | Labor Day | ||
| SEP 14 | Sophie Paczesny MD, PhD | University of Michigan Comprehensive Cancer Center | Biomarkers of Acute Graft vs Host Disease |
| SEP 21 | Jessie Lu | Graduate Student, Division of Clinical Pharmacology | Mechanism of an Adverse Reaction to Methadone During Coadministration of Letrozole |
| SEP 28 | Michael Christman, PhD | President and CEO, Coriell Institute for Medical Research | Using Personal Genome Information in Clinical Care- Challenges and Approaches in the Coriell Personalized Medicine Collaborative |
| OCT 5 | Jacques Turgeon, PharmD | Vice President Research, University of Montreal | Drug-drug interactions and drug-induced Long QT Syndrome |
| OCT 12 | Jeffrey S. Barret, PhD | Associate Professor of Pediatrics, University of Pennsylvania | Modeling in Pediatric Clinical Pharmacology |
| OCT 19 | Todd Skaar, PhD | Associate Professor, Division of Clinical Pharmacology | Drug metabolism and Hot Flashes |
| OCT 26 | No Seminar | ||
| NOV 2 | Lateef Aregbe | Fellow, Division of Clinical Pharmacology, IUSM | PTC299: A genetic approach to biomarker search for a novel anti-VEGF drug |
| NOV 9 | Wolfgang Sadee, Dr.rer.nat. | Professor of Medicine and Chair, Pharmacology Director, Program in Pharmacogenomics, Ohio State University | Discovery of Pharmacogenomic Biomarkers via Expression Genetics |
| NOV 16 | Virginia Vitzthum, PhD | Professor, Department of Anthropology | Human reproductive functioning in diverse environments: Evolutionary and proximate explanations |
| NOV 23 | Thanksgiving | ||
| NOV 30 | Laura Haneline, MD | Associate Professor, Department of Pediatrics | Circulating Progenitor Cells as Potential Biomarkers During Pregnancy |
| DEC 7 | No Seminar | ||
| DEC 14 | Beth Pflug | Associate Research Professor Indiana University School of Medicine Division of Clinical Pharmacology | Energy sensing pathways and misguided lipogenesis in prostate cancer |
| DEC 21 | Holiday | ||
| DEC 28 | Holiday | ||
